This is a likely scenario given that in female MG patients, we only observed significant elevation of serum miR-21-5p in when patients on immunopressive drugs were removed from analysis; this suggests heavy regulation of miR-21-5p by NF-κB. This evidence concerns the gene NFKB1 and myasthenia gravis.